Category Archives for : Uncategorised
Melbourne, Australia, 13 June 2016: Adherium Limited (ASX: ADR), a global leader in digital health technologies that address sub- optimal medication use in chronic disease, today announced that AstraZeneca will.
5,700 Adherium Smartinhaler™ devices plus associated software and communications technologies to be supplied through to 2018 Study in New Zealand, Australia, the United Kingdom & Italy Supply agreement with leading.
August 26, 2015 – Digital health company Adherium Limited (ASX:ADR) ended its first day on the Australian Securities Exchange today with a closing price of 60 cents per share, a.
August 5, 2015 – Australians and New Zealanders have an opportunity to invest in a highly promising digital health technology company that substantially improves medication adherence and patient health outcomes.
July 23, 2015 – New Zealand-based Adherium (NZ) Limited has entered a long term partnership with international pharmaceutical leader AstraZeneca in what the company believes is a world-first commercial arrangement.
Digital health company Nexus6 Limited has changed its name to Adherium as it moves into a phase of rapid growth and international expansion. Following the publication of a number.
A New technology that encourages child asthmatics to take medications has been hailed by experts as a breakthrough device, after a landmark study showed children were 180% more likely to.
Results published today in the prestigious Journal of Allergy and Clinical Immunology (JACI) announce a ground-breaking increase in adherence with asthma medications for patients provided with a novel device called.
Nexus6 Ltd, has received 510(k) marketing clearance from the U.S. Food and Drug Administration (FDA) for its new SmartTouch inhaler monitoring device. It is well known that it is.